Inventec Group's subsidiaries Good Future/Inventec Appliances jointly developed circulating tumor cells (CTCs) automated testing equipment with an All-in-One design and implemented a fully automated testing mode of Sample-in and Data-out. It can know the CTC value in the blood and analyze the risk of cancer through blood testing, which has become a great pride of Taiwan's biotechnology industry.
organizes the highlights of the program and gives everyone a sneak peek!
1. Lin Zhongwei, Vice President of Changhua Xiuchuan Cancer Center, praised cancer cells as the key to cancer metastasis. CTC detection can avoid the shortcomings of traditional imaging examinations and prevent side effects, providing the public with more choices.
2. Vice President Zeng Zhiren of the Affiliated Hospital of Sun Yat-sen Medical University has been using CTC detection in clinical practice for 15 years, benefiting thousands of gynecological tumor patients, and is indeed a golden example of cancer screening in Taiwan.
3. Director Huang Siquan of the Molecular Pathology Department of Da'an United Medical Laboratory also gave a thumbs up, because since the introduction of CTC testing, it can help customers detect cancer as soon as possible and refer them to doctors, and accompany customers to race against time to win the marathon of life.
4. Director Lin Shaozhen of Taichung Pinxin Clinic recommends that people do general health check-ups in conjunction with CTC testing, which is very timely and convenient for cancer screening.
5. Chen Biyu, Vice President of the Health Care Planning Department of Nanshan Life Insurance, cares about the health of the people and provides public spillover insurance policies combined with CTC testing to create a win-win spillover effect.
Don't miss the exciting content!
https://youtu.be/P77Pc0FAOsI
